We have located links that may give you full text access.
Lipoma in dogs under primary veterinary care in the UK: prevalence and breed associations.
Background: Lipomas are masses of mesenchymal origin, comprising of adipocytes, and are often clinically unremarkable but can be alarming to owners. Although lipomas are reportedly common in dogs, no studies have specifically investigated risk factors associated with their occurrence. This study was a large-scale retrospective analysis of electronic patient records of dogs attending practices participating in VetCompass™. Univariable and multivariable logistic regression methods were used to evaluate associations between risk factors and primary-care veterinary diagnosis of lipoma.
Results: From 384,284 dogs under veterinary care during 2013 at 215 primary practice clinics in the UK, there were 2765 lipoma cases identified giving a one-year prevalence of 1.94% (95% CI: 1.87-2.01). Breeds with the highest lipoma prevalence included Weimaraner (7.84%, 95% CI 6.46-9.40), Dobermann Pinscher (6.96%, 95% CI 5.67-8.44), German Pointer (5.23%, 95% CI 3.93-6.80), Springer Spaniel (5.19%, 95% CI 4.76-5.66), and Labrador Retriever (5.15%, 95% CI 4.90-5.41). Dogs with an adult bodyweight equal or higher than their breed/sex mean had 1.96 (95% CI 1.81-2.14, P < 0.001) times the odds of lipoma compared with dogs that weighed below their breed/sex mean. The odds of lipoma increased as adult bodyweight increased. Increased age was strongly associated with increasing odds of lipoma. Compared with dogs aged 3.0 to < 6.0 years, dogs aged 9.0 - < 12.0 years had 17.52 times the odds (95% CI 14.71-20.85, P < 0.001) of lipoma. Neutered males (OR: 1.99, 95% CI 1.69-2.36, P < 0.001) and neutered females (OR: 1.62, 95% CI 1.37-1.91, P < 0.001) had higher odds than entire females. Insured dogs had 1.78 (95% CI 1.53-2.07, P < 0.001) times the odds of lipoma compared with uninsured dogs.
Conclusions: Lipomas appear to be a relatively common diagnosis in primary-care practice. Certain breeds were identified with remarkably high lipoma prevalence, highlighting the risk that owners should be prepared for. Lipoma predisposition of larger bodyweight individuals within breed/sex suggests that being overweight or obese may be a predisposing factor but would need further work to confirm.
Results: From 384,284 dogs under veterinary care during 2013 at 215 primary practice clinics in the UK, there were 2765 lipoma cases identified giving a one-year prevalence of 1.94% (95% CI: 1.87-2.01). Breeds with the highest lipoma prevalence included Weimaraner (7.84%, 95% CI 6.46-9.40), Dobermann Pinscher (6.96%, 95% CI 5.67-8.44), German Pointer (5.23%, 95% CI 3.93-6.80), Springer Spaniel (5.19%, 95% CI 4.76-5.66), and Labrador Retriever (5.15%, 95% CI 4.90-5.41). Dogs with an adult bodyweight equal or higher than their breed/sex mean had 1.96 (95% CI 1.81-2.14, P < 0.001) times the odds of lipoma compared with dogs that weighed below their breed/sex mean. The odds of lipoma increased as adult bodyweight increased. Increased age was strongly associated with increasing odds of lipoma. Compared with dogs aged 3.0 to < 6.0 years, dogs aged 9.0 - < 12.0 years had 17.52 times the odds (95% CI 14.71-20.85, P < 0.001) of lipoma. Neutered males (OR: 1.99, 95% CI 1.69-2.36, P < 0.001) and neutered females (OR: 1.62, 95% CI 1.37-1.91, P < 0.001) had higher odds than entire females. Insured dogs had 1.78 (95% CI 1.53-2.07, P < 0.001) times the odds of lipoma compared with uninsured dogs.
Conclusions: Lipomas appear to be a relatively common diagnosis in primary-care practice. Certain breeds were identified with remarkably high lipoma prevalence, highlighting the risk that owners should be prepared for. Lipoma predisposition of larger bodyweight individuals within breed/sex suggests that being overweight or obese may be a predisposing factor but would need further work to confirm.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app